Daily Stock Analysis, ALQA, Alliqua BioMedical Inc, priceseries

Alliqua BioMedical Inc. Daily Stock Analysis
Stock Information
Open
2.39
Close
2.32
High
2.39
Low
2.25
Previous Close
2.37
Daily Price Gain
-0.05
YTD High
2.85
YTD High Date
Jan 3, 2019
YTD Low
1.81
YTD Low Date
Jan 2, 2019
YTD Price Change
0.33
YTD Gain
16.58%
52 Week High
5.24
52 Week High Date
Nov 28, 2018
52 Week Low
1.55
52 Week Low Date
Oct 24, 2018
52 Week Price Change
0.57
52 Week Gain
32.57%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 1. 2017
5.50
Mar 8. 2017
6.20
5 Trading Days
12.66%
Link
LONG
Jan 2. 2018
1.99
Jan 3. 2018
2.10
1 Trading Days
5.49%
Link
LONG
Jan 4. 2018
2.04
Jan 8. 2018
2.32
2 Trading Days
13.73%
Link
LONG
Apr 5. 2018
2.00
Apr 19. 2018
2.16
10 Trading Days
7.94%
Link
LONG
Aug 16. 2018
2.30
Aug 28. 2018
2.45
8 Trading Days
6.52%
Link
LONG
Nov 28. 2018
2.66
Dec 3. 2018
2.85
3 Trading Days
7.33%
Link
Company Information
Stock Symbol
ALQA
Exchange
NasdaqCM
Company URL
http://www.alliqua.com
Company Phone
215-702-8550
CEO
David Ian Johnson
Headquarters
Pennsylvania
Business Address
1010 STONY HILL ROAD, SUITE 200, YARDLEY, PA 19067
Sector
-
Industry Category
Drugs
Industry Group
Drug Manufacturers - Major
CIK
0001054274
About

Alliqua BioMedical, Inc. is a regenerative technologies company, which commercializes differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. The firm builds a suite of technological solutions that allow clinicians to utilize the latest advances in regenerative therapies to bring improved patient outcomes to their practices. Its commercial wound care portfolio consists of the following product categories: wound bed preparation, human biologics, and antimicrobial protection. The company was founded on October 27, 1997 and is headquartered in Yardley, PA.

Description

Alliqua BioMedical, Inc., a regenerative technologies company, commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing; Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies; and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Alliqua BioMedical, Inc. has a license, marketing, development, and supply agreement with Anthrogenesis Corporation. The company is based in Yardley, Pennsylvania.